z-logo
open-access-imgOpen Access
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Author(s) -
Charles D. Wells,
J. Peter Cegielski,
Lisa Nelson,
Kayla F. Laserson,
Timothy H. Holtz,
Alyssa Finlay,
Kenneth G. Castro,
Karin Weyer
Publication year - 2007
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/518665
Subject(s) - tuberculosis , medicine , outbreak , case fatality rate , public health , transmission (telecommunications) , immunology , multiple drug resistance , virology , mycobacterium tuberculosis , rifampicin , intensive care medicine , drug resistance , environmental health , population , biology , microbiology and biotechnology , pathology , electrical engineering , engineering , nursing
Multidrug-resistant (MDR) tuberculosis (TB) has emerged as a global epidemic, with ~425,000 new cases estimated to occur annually. The global human immunodeficiency virus (HIV) infection epidemic has caused explosive increases in TB incidence and may be contributing to increases in MDR-TB prevalence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom